Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.

Flaherty KR, Wells AU, Cottin V, Devaraj A, Inoue Y, Richeldi L, Walsh SLF, Kolb M, Koschel D, Moua T, Stowasser S, Goeldner RG, Schlenker-Herceg R, Brown KK, INBUILD Trial Investigators

Open source

DOI: 10.1183/13993003.04538-2020
Published: 2022 Mar
Container: The European respiratory journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/13993003.04538-2020,
  title = {Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.},
  author = {Flaherty KR and Wells AU and Cottin V and Devaraj A and Inoue Y and Richeldi L and Walsh SLF and Kolb M and Koschel D and Moua T and Stowasser S and Goeldner RG and Schlenker-Herceg R and Brown KK and INBUILD Trial Investigators},
  year = {2022},
  journal = {The European respiratory journal},
  doi = {10.1183/13993003.04538-2020},
  url = {https://doi.org/10.1183/13993003.04538-2020}
}

RIS

TY  - JOUR
TI  - Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
AU  - Flaherty KR
AU  - Wells AU
AU  - Cottin V
AU  - Devaraj A
AU  - Inoue Y
AU  - Richeldi L
AU  - Walsh SLF
AU  - Kolb M
AU  - Koschel D
AU  - Moua T
AU  - Stowasser S
AU  - Goeldner RG
AU  - Schlenker-Herceg R
AU  - Brown KK
AU  - INBUILD Trial Investigators
PY  - 2022
JO  - The European respiratory journal
DO  - 10.1183/13993003.04538-2020
UR  - https://doi.org/10.1183/13993003.04538-2020
ER  -

APA

KR, F., AU, W., V, C., A, D., Y, I., L, R., SLF, W., M, K., D, K., T, M., S, S., RG, G., R, S., KK, B., & Investigators, I. T. (2022). Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.. The European respiratory journal. https://doi.org/10.1183/13993003.04538-2020

Source records

pubmed · retrieved 2026-09-25T04:30:55.522Z